Lockheed Martin Corporation vs ResMed Inc. — how do they compare? Lockheed Martin Corporation trades at $597.49 (market cap $137.96B), while ResMed Inc. trades at $220.4 (market cap $32.61B). The key difference: Lockheed Martin Corporation is far larger — about 4.2× ResMed Inc.'s market cap, and Lockheed Martin Corporation pays the higher dividend (2.31%). Which is the better fit depends on your goals.
| LMT | RMD | |
|---|---|---|
Market Cap | $137.96B | $32.61B |
Sector | Industrials | Health |
52-Week High | $676.70 | $293.73 |
52-Week Low | $431.56 | $182.82 |
Enterprise Value | $154.71B | $31.97B |
Dividend Yield | 2.31% | 1.17% |
Trailing returns across standard periods
Latest headlines on both assets
Lockheed Martin is the largest defense contractor globally and has dominated the Western market for high-end fighter aircraft since the F-35 program was awarded in 2001. Lockheed's largest segment is aeronautics, which is dominated by the massive F-35 program. Lockheed's remaining segments are rotary and mission systems, which is mainly the Sikorsky helicopter business.
Read more on LMT →ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Read more on RMD →